Search Within

Lymphoma

Formats
  1. Meeting Abstract (1382)
  2. Journal Article (1056)
  3. Book Section (64)
  4. Review (64)
  5. Editorial (38)
  6. Research Letter (38)
  7. Guidelines (18)
  8. Conference Paper (15)
  9. Correspondence (11)
  10. Miscellaneous (5)
  11. Book Whole (4)
Groups
  1. Center for Hematologic Malignancies (2695)
  2. Department of Medicine (2695)
  3. Hematologic Malignancies, Division of (2695)
  4. Population Sciences Research Program (742)
  5. Survivorship Research (655)
  6. Executive Committee, Center for Hematologic Malignancies (391)

More Groups

People
  1. Andrew Zelenetz (781)
  2. Steven Horwitz (664)
  3. Maria Palomba (444)
  4. Ariela Noy (369)
  5. David Straus (360)
  6. Alison Moskowitz (355)

More People

Years
  1. 2025 (42)
  2. 2024 (141)
  3. 2023 (180)
  4. 2022 (170)
  5. 2021 (171)
  6. 2020 (170)

More Years

Publications
  1. Blood (876)
  2. Journal of Clinical Oncology (277)
  3. Hematological Oncology (110)
  4. British Journal of Haematology (81)
  5. Leukemia and Lymphoma (81)
  6. Haematologica (71)

More Publications

Publishers
  1. American Society of Hematology (941)
  2. American Society of Clinical Oncology (293)
  3. Elsevier Inc. (187)
  4. Wiley Blackwell (174)
  5. John Wiley & Sons (96)
  6. Nature Publishing Group (93)

More Publishers

Results (2695)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Medical oncologists' clinical experiences and comfort levels with 20 recently approved agents
    Meeting Abstract

    Love, N.; Anderson, K. C.; Flaherty, K.; Kantarjian, H. M.; Lynch, T. J.; O'Shaughnessy, J.; Sartor, A. O.; Venook, A. P.; Zelenetz, A. D.; Moss, J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase I study of ISIS 481464 (AZD9150), a first-in-human, first-in-class, antisense oligonucleotide inhibitor of STAT3, in patients with advanced cancers
    Meeting Abstract

    Hong, D. S.; Younes, A.; Fayad, L.; Fowler, N. H.; Hagemeister, F. B.; Mistry, R.; Nemunaitis, J. J.; Borad, M. J.; Bryce, A. H.; Yamashita, M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Preliminary safety and efficacy of IPI-145, a potent inhibitor of phosphoinositide-3-kinase-δ,γ in patients with relapsed/refractory lymphoma
    Meeting Abstract

    Horwitz, S. M.; Flinn, I.; Patel, M. R.; Younes, A.; Foss, F. M.; Oki, Y.; Sweeney, J.; Allen, K.; Dunbar, J.; Kelly, P. F.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A pooled analysis of 1,546 patients with AIDS-related lymphoma (ARL): An assessment of prognostic factors by treatment era
    Meeting Abstract

    Barta, S. K.; Samuel, M.; Xue, X.; Lee, J. Y.; Mounier, N.; Kaplan, L. D.; Ribera, J. M.; Spina, M.; Tirelli, U.; Weiss, R.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • ABT-888 plus bendamustine is safe and has shown preliminary efficacy in patients with lymphoma
    Meeting Abstract

    Gerecitano, J. F.; Schwartz, G. K.; Carvajal, R.; Fury, M.; Konner, J.; Hyman, D. M.; Gounder, M.; Gajria, D.; Teitcher, J.; Zhang, Z.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Pancreatitis in patients treated with brentuximab vedotin: A previously unrecognized serious adverse event
    Meeting Abstract

    Gandhi, M.; Evens, A. M.; Fenske, T. S.; Hamlin, P.; Coiffier, B.; Engert, A.; Moskowitz, A. J.; Ghosh, N.; Petrich, A. M.; Lomasney, J.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Brentuximab vedotin administered before, during, and after multi-agent chemotherapy in patients (pts) with newly-diagnosed CD30+ mature T- and NK-cell lymphomas
    Meeting Abstract

    Fanale, M. A.; Horwitz, S. M.; Forero-Torres, A.; Bartlett, N. L.; Advani, R. H.; Pro, B.; Chen, R.; Davies, A.; Illidge, T.; Huebner, D.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Characterizing the CpG methylation of Epstein-Barr virus DNA in the plasma of patients with Hodgkin lymphoma and HIV-associated Burkitt lymphoma
    Meeting Abstract

    Kanakry, J. A.; Shamay, M.; Kasamon, Y. L.; Li, H.; Gascoyne, R. D.; Gordon, L. I.; Noy, A.; Cesarman, E.; Lee, J. Y.; Horning, S. J.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • PET compared with CT as a prognosticator after rituximab induction therapy in follicular lymphoma: Report from the National Lymphocare Study
    Meeting Abstract

    Wong-Sefidan, I.; Byrtek, M.; Zhou, X.; Friedberg, J. W.; Flowers, C.; Link, B. K.; Zelenetz, A. D.; Dawson, K. L.; Reid, E. G.
    Blood (2013)

    Fulltext@MSK | Save
  • Cross-platform assessment of genomic imbalance in diffuse large B-cell lymphoma identifies novel candidate loci and genes with prognostic value and roles in lymphomagenesis
    Meeting Abstract

    Dias, L.; Thodima, V.; Mendiratta, G.; Asha, G.; Gonzalez, C.; Maragulia, J. C.; Zelenetz, A. D.; Feldstein, J. T.; Chaganti, R. S. K.; Houldsworth, J.
    Blood (2013)

    Fulltext@MSK | Save